Evaluation of Clinical and Quality of Life Effects of Oral Semaglutide Use in Type 2 Diabetes from a Public Health View: A Prospective Study in Italy

<b>Background and Aim:</b> Type 2 diabetes (T2D) continues to pose a significant public health challenge worldwide. Among therapeutic options, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have proven effective in optimizing glycemic control and improving cardiometabolic profiles. Semaglutid...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Paola Pantanetti, Vanessa Ronconi, Stefano Mancin, Cristina De Carolis, Sara Alberti, Orietta Pazzi, Sandra Di Marco, Grazia Michetti, Silvia Coacci, Veronica Mignini, Franco Gregorio, Giulia Baldoni, Sara Toderi, Sara Morales Palomares, Fabio Petrelli, Gabriele Caggianelli, Mauro Parozzi, Giovanni Cangelosi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2025-08-01
Saila:	Diabetology
Gaiak:	oral semaglutide type 2 diabetes quality of life prospective cohort study public health
Sarrera elektronikoa:	https://www.mdpi.com/2673-4540/6/8/80
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!